Bandingkan Harga & Kinerja Maskapai Reasuransi Indonesia Tbk. (MREI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Maskapai Reasuransi Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Maskapai Reasuransi Indonesia Tbk. diperdagangkan di Rp920 (kapitalisasi pasar 476,37 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Maskapai Reasuransi Indonesia Tbk. jauh lebih besar — sekitar 4,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MREI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 476,37 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Maskapai Reasuransi Indonesia Tbk.
PT Maskapai Reasuransi Indonesia Tbk (the Company) was established on 4th June 1953 based on Notarial Deed No. 15 of Anton Frederik Schut a substitute of Meester Karel Esuard Krijgsman, notary in Jakarta.In 1998 PT. Dharmala Sakti Sejahtera became one of Marein’s major shareholders, besides AJB Bumiputera 1912, and as the result the company was able to increase its paid up capital to Rp 3,002,500,000.
Selengkapnya di halaman MREI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
